Evaluate pathology AI tools for slide workflow fit, regulatory scope, image quality, lab validation, privacy, and pathologist oversight.
Pathology groups, health systems, digital pathology teams, oncology programs, laboratory directors, and AI governance committees.
Pathology AI depends on scanner, stain, tissue, LIS, and pathologist-review workflows, so validation has to happen inside the lab's actual diagnostic process.
| Medical risk | High |
|---|---|
| Best first step | Write the workflow in one sentence, decide who reviews the AI output, and test with a small controlled pilot before expanding. |
| Recommended posture | Use AI as supervised workflow support. Verify sources, privacy, human review, and regulatory fit before relying on outputs. |
These profiles are not rankings. They are starting points for checking vendor claims, privacy terms, FDA or regulatory posture, evidence, and workflow fit.
Paige describes AI applications for cancer pathology and a prostate suite for detection and diagnosis support.
PathAI says AISight powers digital pathology workflows and AI applications; AISight Dx materials describe FDA-cleared primary-diagnosis image management with specified scanner support, while other AI algorithms and research workflows require separate intended-use review.
Roche describes navify Digital Pathology as enterprise pathology software for case workflow, multi-slide viewing, annotation, collaboration, cloud or on-prem deployment, scanner interoperability, PACS and navify Pathology Lab Hub integration, and access to AI-based image analysis algorithms through Roche Open Environment. Roche labeling materials describe Roche Digital Pathology Dx as an aid for qualified pathologists reviewing FFPE whole-slide images and state limits for other applications, while FDA records list Roche Digital Pathology Dx 510(k) clearances K232879 and K242783.
Ibex describes an AI-powered pathology platform for automated insights across cancer workflows, structured reporting partnerships, regulatory distinctions by solution and region, a U.S. 510(k)-cleared Galen Second Read prostate workflow, and published privacy and compliance materials.
Open these vendor, documentation, privacy, or regulatory sources before relying on product claims, especially for FDA status, PHI handling, deployment model, and intended use.
Compare digital pathology products · Open the category shortlist · Review source policy
Find the best AI for medical workflows by matching the tool to documentation, questions, diagnosis support, research, coding, billing, imaging, or practice operations.
Compare AI tools for medical questions by source visibility, recency, hallucination controls, medical disclaimers, and clinician review.
Understand AI for medical diagnosis, including validation evidence, FDA status, clinical supervision, and why patient-specific diagnosis should not rely on general chatbots.
Evaluate AI for medical imaging by modality, intended use, FDA record, validation evidence, radiology workflow, and monitoring requirements.
Compare chest X-ray AI tools by finding scope, FDA or CE status, triage versus detection use, PACS workflow, privacy, and radiologist review.
Evaluate AI for medical charting by note quality, clinician review, EHR workflow, BAA terms, audio retention, and auditability.